Table 1.
Female | Male | |||||||
---|---|---|---|---|---|---|---|---|
Week 1 | Week 1 | Week 6 | Week 6 | Week 1 | Week 1 | Week 6 | Week 6 | |
Sham | MI | Sham | MI | Sham | MI | Sham | MI | |
MI size(%) | ---- | 44±5 | ---- | 42±9 | ---- | 42±3 | ---- | 42±7 |
SLA (mm) | 4±0.5 | 4.9±11 | 4±0.2 | 6±1*# | 3±0.5 | 5±1* | 3±0.4 | 6±1*# |
SLA/BW(mm/g) | 0.02± 0.001 | 0.02±0.0005* | 0.02±0.002 | 0.03±0.003* | 0.01±0.002 | 0.02±0.0005* | 0.01±0.0003 | 0.02±0.002* |
LVDD(mm) | 5±0.5 | 8±0.5* | 5±1 | 9±1*# | 4±1 | 9±1* | 5±1 | 10±0.01*# |
LVDD/BW(mm/g) 0.03± 0.002 | 0.04±0.003* | 0.03±0.001 | 0.04±0.01* | 0.03±0.001 | 0.04±0.005* | 0.03±0.002 | 0.03±0.005* | |
LVSD(mm) | 2±0.3 | 6±1* | 3±1 | 7±1*# | 2±1 | 7±0.3* | 3±1 | 8±0.3*# |
LVSD/BW(mm/g) 0.02± 0.002 | 0.03±0.0004* | 0.02±0.0001 | 0.03±0.01* | 0.02±0.0001 | 0.03±0.005* | 0.02±0.0002 | 0.03±0.005* |
MI=myocardial infarction; BW=body weight; SLA=left atrium size; LVDD=left ventricle diastolic diameter; LVSD=left ventricle systolic diameter Data are shown as means±SD. Two-way ANOVA and Bonferroni tests were applied for comparisons.
P<0.05 vs. Sham on first and sixth week.
P<0.05 vs. MI on first week